NO153368B - PROCEDURE FOR THE PREPARATION OF 10-OXO-10,11-DIHYDRO-5H-DIBENZ (B, F) -ASEPINE-5-CARBOXAMIDE - Google Patents

PROCEDURE FOR THE PREPARATION OF 10-OXO-10,11-DIHYDRO-5H-DIBENZ (B, F) -ASEPINE-5-CARBOXAMIDE Download PDF

Info

Publication number
NO153368B
NO153368B NO803229A NO803229A NO153368B NO 153368 B NO153368 B NO 153368B NO 803229 A NO803229 A NO 803229A NO 803229 A NO803229 A NO 803229A NO 153368 B NO153368 B NO 153368B
Authority
NO
Norway
Prior art keywords
dibenz
carboxamide
azepine
dihydro
oxo
Prior art date
Application number
NO803229A
Other languages
Norwegian (no)
Other versions
NO153368C (en
NO803229L (en
Inventor
Jacques Gosteli
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO803229L publication Critical patent/NO803229L/en
Publication of NO153368B publication Critical patent/NO153368B/en
Publication of NO153368C publication Critical patent/NO153368C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines

Description

Oppfinnelsens gjenstand er en ny og fordelaktig fremgangsmåte til fremstilling av 1O-okso-10,11-dihydro-5H-dibenz(b,f)asepin-5-<k>arboksamid med formel The object of the invention is a new and advantageous process for the preparation of 1O-oxo-10,11-dihydro-5H-dibenz(b,f)azepine-5-<k>arboxamide with the formula

idet fremgangsmåten er karakterisert ved at 10-klor-5H-dibenz (b, f) azepin-5- karboksamid med formel in that the method is characterized by the fact that 10-chloro-5H-dibenz (b, f) azepine-5-carboxamide with the formula

hydrolyseres ved hjelp av 90-96% svovelsyre ved en temperatur pa10-30°C. is hydrolyzed using 90-96% sulfuric acid at a temperature of 10-30°C.

Fra tysk off. skrift nr. 2.01 1 .087 er det kjent en fremgangsmåte til fremstilling av 10-okso-10,11-dihydro-5H-dibenz(b,f,)asepin-5-karboksamid idet 10-metoksy-5H-dibenz(b,f)asepin-5-karboksamid hydrolyseres ved hjelp av en mineralsyre, f.eks. fortynnet saltsyre ved tilbakeløpstemperatur. Fremstillingen av dette utgangsmaterialet foregår som angitt ved omsetning av 10-metoksy-5H-dibenz(b,f)asepin med fosgen eller tilsvarende 5-karbonylklorid og dets omsetning med ammoniakk til 10-metoksy-5H-dibenz(b,f)asepin-5-karboksamid. Det nødvendige 10-matoksy-5H-dibenz(b,f)-asepin igjen, er ifølge angivelser i belgisk patent nr. 597.793 tilgjengelige fra 5-acetyl-5H-dibenz(b,f)-asepin og det derav ved hjelp av addisjon av brom, fremstHlbare 5-acetyl-10,11-dihydro-10,11-dibrom-5H-dibenz(b,f)-asepin, dets ometning med kaliumhydroksyd til 5-acetyl-10-brom-5H-dibenz (b,f)asepin og dets reaksjoner med natriummetylat eller direkte omsetning From German off. publication no. 2.01 1.087, a method for the production of 10-oxo-10,11-dihydro-5H-dibenz(b,f,)azepine-5-carboxamide is known, wherein 10-methoxy-5H-dibenz(b, f) azepine-5-carboxamide is hydrolysed with the aid of a mineral acid, e.g. dilute hydrochloric acid at reflux temperature. The production of this starting material takes place as indicated by reaction of 10-methoxy-5H-dibenz(b,f)azepine with phosgene or corresponding 5-carbonyl chloride and its reaction with ammonia to 10-methoxy-5H-dibenz(b,f)azepine- 5-carboxamide. The necessary 10-methoxy-5H-dibenz(b,f)-azepine again, according to indications in Belgian patent no. 597,793, is available from 5-acetyl-5H-dibenz(b,f)-azepine and the derivative by means of addition of bromine, preparable 5-acetyl-10,11-dihydro-10,11-dibromo-5H-dibenz(b,f)-azepine, its transsaturation with potassium hydroxide to 5-acetyl-10-bromo-5H-dibenz (b, f)azepine and its reactions with sodium methylate or direct reaction

av overnevnte bromaddisjonsprodukt, med minst den dobbeltmolare mengde, fortrinnsvis et større overskudd av natriummetylat. of the above-mentioned bromine addition product, with at least the double molar amount, preferably a larger excess of sodium methylate.

Ulemper ved denne i og for seg allerede omstendelige fremgangsmåten til fremstilling av det nødvendige utgangsstoff, ligger spesielt også i det relativt høye forbruk av brom, som bare tjener til innføring og omdannelse av funksjonelle' grupper. Disadvantages of this, in and of itself, already cumbersome method for producing the necessary starting material, lie in particular also in the relatively high consumption of bromine, which only serves for the introduction and conversion of functional groups.

Disse ulemper unngås i forbindelse med fremgangsmåten ifølge oppfinnelsen, idet man anvender det hertil nødvendige utgangsmateriale som ifølge DOS 2.542.335 enten er tilgjengelig ved omsetning av 5-acetyl-5H-diben;z (b,f)asepin med klor til 5-acetyl-10,11-diklor-10,11, dihydro-5H-diben:z(b,f)asepin, dets omdannelse ved hjelp av en tertier organisk base, som f.eks. diisopropyletyl-amin, til 5-acetyl-10-klor-5H-dibenz(b,f)asepin, fulgt av dets hydrolyse ved hjelp av bromhydrogensyre til 10-klor-5H-dibenz(b,f)asepin, dets omsetning med fosgen til det tilsvarende 5-karbonylklorid og endelig dets reaksjon med ammoniakk, eller ved addisjon av klor til 5H-dibenz (b,f)asepin-5-karboksamid og behandling av det dannede 10,11-diklor-10,11-dihydro-5H-dibenz(b,f)-asepin-5-karboksamid, med en tertiær organisk base, som f.eks. 1,5-diasabicyklo (4,3,0)non-5-en. These disadvantages are avoided in connection with the method according to the invention, by using the necessary starting material which, according to DOS 2,542,335, is either available by reacting 5-acetyl-5H-diben;z (b,f)azepine with chlorine to 5-acetyl -10,11-dichloro-10,11, dihydro-5H-diben:z(b,f)azepine, its conversion by means of a tertiary organic base, such as diisopropylethylamine, to 5-acetyl-10-chloro-5H-dibenz(b,f)azepine, followed by its hydrolysis with hydrobromic acid to 10-chloro-5H-dibenz(b,f)azepine, its reaction with phosgene to the corresponding 5-carbonyl chloride and finally its reaction with ammonia, or by addition of chlorine to 5H-dibenz (b,f)azepine-5-carboxamide and treatment of the formed 10,11-dichloro-10,11-dihydro-5H -dibenz(b,f)-azepine-5-carboxamide, with a tertiary organic base, such as e.g. 1,5-diasabicyclo(4,3,0)non-5-ene.

Fra Heiv.chim.Acta Vol. 55, side 451-60, (1972), From Heiv.chim.Acta Vol. 55, pages 451-60, (1972),

er det kjent omdannelsen av i metylenklorid oppløst 2-okso-3-(2-nitro-3-klor-fenyl)-5-klor-5-hexensyre-etylester ved hjelp av -15°C avkjølt konsentrert svovelsyre til 2,5-diokso-3-klorfenyl)hexan-syre-etylester. it is known the conversion of 2-oxo-3-(2-nitro-3-chloro-phenyl)-5-chloro-5-hexenoic acid ethyl ester dissolved in methylene chloride by means of -15°C cooled concentrated sulfuric acid to 2,5- dioxo-3-chlorophenyl)hexane acid ethyl ester.

I J.Amer.Chem.Sos. 88, 4290-91 (1966) omtales en In J. Amer. Chem. Sos. 88, 4290-91 (1966) one is mentioned

enkel fremgangsmåte til fremstilling av cykloalkanoner av forskjellig ringstørrelse, idet man i en egnet nukleofil forbindelse innfører B-klorallylgruppen som ved hydrolyse ved hjelp av maursyre eller 90%- ig svovelsyre omdannes i det tilsvarende mettede keton. Således dannes f.eks. 1 -(2-klor-allyl)-inden ved simple method for the preparation of cycloalkanones of different ring sizes, by introducing the B-chlorallyl group into a suitable nucleophilic compound which, by hydrolysis with the aid of formic acid or 90% sulfuric acid, is converted into the corresponding saturated ketone. Thus, e.g. 1 -(2-chloro-allyl)-indene by

hjelp av 97%- ig maursyre og etterfølgende behandling med vann til 3,5-(o-fenylen)-cyklohexanon. using 97% formic acid and subsequent treatment with water to 3,5-(o-phenylene)-cyclohexanone.

I avhengighet at det anvendte utgangsmaterialstruktur, kan anvendelsen av 97%- ig svovelsyre ved 0°C være mer fordelaktig isteden for maursyre. Depending on the starting material structure used, the use of 97% sulfuric acid at 0°C may be more advantageous instead of formic acid.

Overraskende ble det nå funnet, at ved fremgangsmåten ifølge oppfinnelsen, gjennomføres hydrolysen av 10-klor-5H-diben I(b,f)asepin5-karboksamid til 10-okso-10,11-dihydro-5H-diben z(b,f)asepin-5- Surprisingly, it was now found that with the method according to the invention, the hydrolysis of 10-chloro-5H-dibene I(b,f)azepine 5-carboxamide is carried out to 10-oxo-10,11-dihydro-5H-dibene z(b,f )azepin-5-

karboksamid ved hjelp av konsentrert svovelsyre ved normaltemperaturr Med konsentrert svovelsyre forstås her 90-96%-ig fortrinnsvis 96%-ig svovelsyre.. Reaksjonstemperaturen ligger f.eks. ved 10-30°C, fortrinnsvis ved 15-25°C. carboxamide using concentrated sulfuric acid at normal temperatures By concentrated sulfuric acid is meant here 90-96% preferably 96% sulfuric acid. The reaction temperature is e.g. at 10-30°C, preferably at 15-25°C.

Det kunne ikke ventes at under betingelsene for fremgangsmåten ifølge oppfinnelsen ville urinstoff-gruppene ikke angripes, da det er kjent at urinstoff-forbindelser hydroliserer ved hjelp av vandige syrer, spesielt ved for høy temperatur. Således er det fra "Berichte der Deutschen Chemischen Gesellschaft" It could not be expected that under the conditions of the method according to the invention the urea groups would not be attacked, as it is known that urea compounds hydrolyze with the aid of aqueous acids, especially at too high a temperature. Thus it is from the "Berichte der Deutschen Chemischen Gesellschaft"

9 (1978), side 397, kjent at usymmetrisk difenyl-urinstoff ved oppvarming med svovelsyre gir en blå oppløsning, som tydeligvis forårsakes av difenyl- 9 (1978), page 397, it is known that unsymmetrical diphenylurea when heated with sulfuric acid gives a blue solution, which is evidently caused by diphenyl-

amin, for, ifølge Merck Index utgitt av Merck & Co., amine, for, according to the Merck Index published by Merck & Co.,

Inc. Rahway, N.J. (USA), 9. utgave, (1976), side Inc. Rahway, N.J. (USA), 9th ed., (1976), p

443-444 gir difenylamin en dyp blåfarge med svovelsyre. Det med den nye fremgangsmåte oppnådde tekniske fremskritt består videre i at hydrolysen ifølge oppfinnelsen i det vesentlige foregår ved værelsestemperatur, således at faren for korrosjonsbeskadigelser på anvendte metalliske reaksjonskar minskes, mens den kjente hydrolysefremgangsmåten foregår ved hjelp at mineralsyre ved tilbakeløpstemperatur hvor ved korrosjons-belastningen er øket sterkt. 443-444 diphenylamine gives a deep blue color with sulfuric acid. The technical progress achieved with the new method further consists in the fact that the hydrolysis according to the invention essentially takes place at room temperature, so that the risk of corrosion damage to the metallic reaction vessels used is reduced, while the known hydrolysis method takes place with the help of mineral acid at reflux temperature where the corrosion load is increased greatly.

Derimot fåes fremgangsmåten ifølge oppfinnelsen 10-okso-10,11-dihydro-5H-dibenz(b,f)asepin-5-karboksamid i et utbytte på 64%, referert til omsatt utgangs-material, og i god renhet. In contrast, the method according to the invention obtains 10-oxo-10,11-dihydro-5H-dibenz(b,f)azepine-5-carboxamide in a yield of 64%, referred to reacted starting material, and in good purity.

Oppfinnelsen skal forklares nærmere ved hjelp av The invention shall be explained in more detail by means of

følgende eksempel. the following example.

Eksempel Example

I en ved hjelp av et med kalsiumklorid fylt tørkerør lukket rundkolbe, omrøres blandingen av 0,5g 10-klor-5H-dibenz (b,f)asepin-5-karboksamid og 5 ml konsentrert svovelsyre (96%-ig) i 10 minutter ved væreIsestemperatur, hvoretter man får en klar gulaktig oppløsning. Omrøringen fortsettes over 76 timer ved værelsestemperatur, idet det oppstår en klar, brun oppløsning. Man heller reaksjonsblandingen på 100 g is, og 100 ml metylenklorid, adskiller den organiske fasen, vasker den vandige oppløsningen fire ganger med hver gang 80 ml metylenklorid, og vasker de forended organiske oppløsninger (480 ml) tre ganger med halvmettet vandig natriumkloridoppløsning, tørker over natriumsulfat og inndamper under nedsatt trykk til tørrhet. Stir the mixture of 0.5g of 10-chloro-5H-dibenz(b,f)azepine-5-carboxamide and 5 ml of concentrated sulfuric acid (96%) in a round flask closed using a drying tube filled with calcium chloride for 10 minutes at room temperature, after which a clear yellowish solution is obtained. Stirring is continued over 76 hours at room temperature, as a clear, brown solution is formed. The reaction mixture is poured onto 100 g of ice and 100 ml of methylene chloride, the organic phase is separated, the aqueous solution is washed four times with 80 ml of methylene chloride each time, and the finished organic solutions (480 ml) are washed three times with half-saturated aqueous sodium chloride solution, dried over sodium sulfate and evaporate under reduced pressure to dryness.

Residivet omkrystalliseres fra metylenklorid/eter, hvoretter man får ren 10-okso-11-dihydro-5H-dibenz(b,f)asepin-5-karboksamid av.smeltepunkt 213-215°C. Utbytte referert til omsatt utgangsmateriale 6 4% av det teoretiske. The residue is recrystallized from methylene chloride/ether, after which pure 10-oxo-11-dihydro-5H-dibenz(b,f)azepine-5-carboxamide of melting point 213-215°C is obtained. Yield referred to converted starting material 6 4% of the theoretical.

Claims (1)

1. Fremgangsmåte til fremstilling av 10-oksb-10,11-dihydro-5H-dibenz(b,f)asepin-5-karboksamid med formel1. Process for the preparation of 10-oxb-10,11-dihydro-5H-dibenz(b,f)azepine-5-carboxamide with formula karakterisert ved at 10-klor-5H-dibenz(b,f)asepin-5-karboksamid med formelcharacterized in that 10-chloro-5H-dibenz(b,f)azepine-5-carboxamide with formula hydrolyseres ved hjelp av 96%-ig svovelsyre ved en temperatur på 10-30°C.is hydrolyzed using 96% sulfuric acid at a temperature of 10-30°C.
NO803229A 1979-10-30 1980-10-29 PROCEDURE FOR THE PREPARATION OF 10-OXO-10,11-DIHYDRO-5H-DIBENZ (B, F) -ASEPIN-5-CARBOXAMIDE. NO153368C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH970479A CH642950A5 (en) 1979-10-30 1979-10-30 Process for the preparation of 10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide

Publications (3)

Publication Number Publication Date
NO803229L NO803229L (en) 1981-05-04
NO153368B true NO153368B (en) 1985-11-25
NO153368C NO153368C (en) 1986-03-05

Family

ID=4354741

Family Applications (1)

Application Number Title Priority Date Filing Date
NO803229A NO153368C (en) 1979-10-30 1980-10-29 PROCEDURE FOR THE PREPARATION OF 10-OXO-10,11-DIHYDRO-5H-DIBENZ (B, F) -ASEPIN-5-CARBOXAMIDE.

Country Status (7)

Country Link
JP (1) JPS5673066A (en)
AT (1) AT375926B (en)
CH (1) CH642950A5 (en)
DK (1) DK457680A (en)
ES (1) ES8200097A1 (en)
NO (1) NO153368C (en)
SE (1) SE447106B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112812D0 (en) * 2001-05-25 2001-07-18 Portela & Ca Sa Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom
GB2401605A (en) 2003-05-12 2004-11-17 Portela & Ca Sa Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide and optically enriched mixtures thereof
GB2422149A (en) 2005-01-14 2006-07-19 Portela & Ca Sa Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide
WO2007141798A1 (en) * 2006-06-07 2007-12-13 Jubilant Organosys Limited Process for producing oxcarbazepine via an 11-alkoxy-10-halo-dihydroiminostilbene intermediate

Also Published As

Publication number Publication date
DK457680A (en) 1981-05-01
CH642950A5 (en) 1984-05-15
ATA531980A (en) 1984-02-15
SE8007597L (en) 1981-05-01
AT375926B (en) 1984-09-25
ES496332A0 (en) 1981-10-16
SE447106B (en) 1986-10-27
ES8200097A1 (en) 1981-10-16
NO153368C (en) 1986-03-05
NO803229L (en) 1981-05-04
JPS5673066A (en) 1981-06-17

Similar Documents

Publication Publication Date Title
CA2954276C (en) Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids
KR19990044234A (en) Method for preparing quinazoline derivatives
US4452738A (en) Process for the manufacture of 5-carbamoyl-10-oxo-10,11-dihydro-5H-dibenz[b,]azepine
NO153368B (en) PROCEDURE FOR THE PREPARATION OF 10-OXO-10,11-DIHYDRO-5H-DIBENZ (B, F) -ASEPINE-5-CARBOXAMIDE
JPH0248548B2 (en)
HU182436B (en) Process for producing 2,3,4,5-tetrahydro-1-benzoxepine-3,5-dion derivatives
SU1301311A3 (en) Method for producing derivatives of hexahydroazepine,or piperidine,or pyrrolidine (versions)
KR100486320B1 (en) Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one
KR100856133B1 (en) Improved process for preparing atorvastatin
EP0040418B1 (en) Process for preparing an 1h-indazol-3-ylacetic acid derivative
JP3563424B2 (en) Method for producing 4H-pyran-4-one
KR101302083B1 (en) Method for the production of substituted 2-alkoxycarbonyl-3-aminothiophenes
KR0127251B1 (en) Process for preparing of 4,4&#39;-bischloro-methylbiphenyl
KR890002251B1 (en) Process for preparing oxazole compound
JPS6054948B2 (en) Method for producing aromatic amines from α,β↓-unsaturated cycloaliphatic ketoxime
KR100441348B1 (en) A Method for the Preparation of 6-Morphanthridone, the Intermediate of Epinastine
KR850000944B1 (en) Process for preparing 5-carbamoyl-10,11-dihydro 5h-dibenz(b,f)azepine
RU1797608C (en) Process for preparing 2@-methyl-trans-decahydroquinolone-4
SU1077877A1 (en) Process for preparing methyl-derivatives of cyclohexane-1,4-dione
FI64373B (en) FRAMEWORK FOR FRAMEWORK OF BASIC SUBSTITUTES ALKYLTEOFYLLINDERIVAT
KR100516383B1 (en) New manufacturing process of dihydrocarbostyril derivatives
KR100898099B1 (en) Process for preparation of Zaltoprofen
JPS607988B2 (en) Improved synthesis method of 3-amino-5-tert-butyl isoxazole
JPS63216861A (en) Production of 4-hydroxyindolines
KR20020073980A (en) New preparing method of dibenzothiepin derivatives